Genprex, Inc. (GETTEX:2DE) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John N Bonfiglio Other companies: Qrons Inc (Chief Operating Officer · Jul 1, 2019 – Jul 1, 2019 · Past); Marker Therapeutics, Inc. (President and COO, Director · Jul 23, 2015 – Mar 9, 2017 · Past); Oragenics Inc. (President and CEO, Director · May 25, 2011 – Aug 13, 2014 · Past); Harrow, Inc. (President and CEO, Director · Oct 20, 2010 – Oct 20, 2010 · Past) | Director · Feb 12, 2019 – Feb 12, 2019 · Past |
| Catherine M Vaczy Other companies: Lisata Therapeutics, Inc. (General Counsel · Oct 31, 2008 – Apr 13, 2015 · Past) | EVP GC Chief Strategy Officer · Mar 12, 2020 – Apr 21, 2023 · Past |
| Mark Stanley Berger Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Chief Medical Officer · Mar 16, 2017 – Sep 1, 2021 · Past) | Chief Medical Officer · Since at least Sep 27, 2021 |
| Brent Longnecker | Director · Since at least Apr 14, 2026 |
| Celina Laney | Chief of Staff · Since at least Nov 5, 2026 |
| Greg Jancarik | Senior Director and Corporate Controller · Since at least Nov 4, 2026 |
| Hermant Kumar | Chief Mfgr & Tech Officer · Sep 27, 2021 – Feb 18, 2023 · Past |
| John Rodney Varner | Chairman, President and CEO, Director · Mar 28, 2018 – Feb 18, 2024 · Past |
| Jose A. Moreno Toscano | Board Chairman · Since at least Nov 5, 2026 |
| Kalyn Dabbs | Director of Communications · Since at least Oct 28, 2026 |
| Kate Combs | Vice President of Clinical Operations · Since at least Nov 4, 2026 |
| Robert W Pearson | Director · Mar 28, 2018 – Dec 30, 2019 · Past |
| Ryan M. Confer | President, Chief Executive Officer, Chief Financial Officer · Since at least Jul 28, 2022 |
| Tracy Huynh | Accounting Manager · Since at least Nov 5, 2026 |
| William Wilson | Board Director · Since at least Nov 5, 2026 |